Lauxera Growth I, a fund managed by Lauxera Capital Partners; Nov Santé Actions Non Cotées, a fund managed by Eurazeo SE (ENXTPA:RF); Relyens SAS; and Ludovic de Saint Jean, Founder and Chief Executive Officer of Groupe PSIH acquired an unknown majority stake in Groupe PSIH from Ludovic de Saint Jean and others.
September 13, 2021
Share
Lauxera Growth I, a fund managed by Lauxera Capital Partners; Nov Santé Actions Non Cotées, a fund managed by Eurazeo SE (ENXTPA:RF), Relyens SAS; and Ludovic de Saint Jean, Founder and Chief Executive Officer of Groupe PSIH acquired an unknown majority stake in Groupe PSIH from Ludovic de Saint Jean and others on September 14, 2021. Lauxera acquired a majority stake, alongside Ludovic de Saint Jean who reinvested, Eurazeo and Relyens. The transaction has been financed via equity and debt by a pool of banks comprising BNP Paribas, LCL and CIC Lyonnaise de Banque. Groupe PSIH had turnover of nearly €11 million in 2020. Maxence Bloch, David Diamant, François Scheffer, and Charles-Henri de Gouvion Saint Cyr of Goodwin Procter acted as legal advisors to Lauxera and Eurazeo.
Lauxera Growth I, a fund managed by Lauxera Capital Partners; Nov Santé Actions Non Cotées, a fund managed by Eurazeo SE (ENXTPA:RF), Relyens SAS; and Ludovic de Saint Jean, Founder and Chief Executive Officer of Groupe PSIH completed the acquisition of an unknown majority stake in Groupe PSIH from Ludovic de Saint Jean and others on September 14, 2021. Damien Moron of KPMG S.A. provided financial due diligence to buyers while Albane Eglinger and Laurent Tasocak of KPMG Avocats provided legal due diligence. Damien Dixsaut of Ernst & Young France provided IP/IT due diligence. Maxence Bloch, David Diamant, François Scheffer, and Charles-Henri de Gouvion Saint Cyr of Goodwin Procter acted as legal due diligence provider to buyers. Sébastien Chabre and Hubert Béranger of Transactions & Cie acted as financial advisors to sellers while Laurent Simon of AlcyaConseil provided legal advice. Olivier Poncin and Thibault Fleury of Advance Capital acted as financial due diligence provider to sellers. Christophe Gaillard and Thibault Lechoux of De Pardieu Brocas Maffei provided legal advice to lenders.
Eurazeo SE is a leading European investment group with diversified assets under management of EUR 33.5 billion, including EUR 23 billion on behalf of institutional and individual clients through its private equity, private debt, real estate and infrastructure strategies. The group supports over 600 mid-market companies, leveraging the commitment of its 400 employees, its sector expertise, its privileged access to global markets via 12 offices in Europe, Asia and the United States, and its responsible approach to value creation based on growth. Eurazeo's institutional and family shareholding and its solid financial structure ensure its long-term viability.
Eurazeo SE has offices in Paris, New York, London, Frankfurt, Berlin, Milan, Madrid, Luxembourg, Shanghai, Seoul, Singapore and Saõ Paulo.
Lauxera Growth I, a fund managed by Lauxera Capital Partners; Nov Santé Actions Non Cotées, a fund managed by Eurazeo SE (ENXTPA: RF); Relyens SAS; and Ludovic de Saint Jean, Founder and Chief Executive Officer of Groupe PSIH acquired an unknown majority stake in Groupe PSIH from Ludovic de Saint Jean and others.